U.S.: FDA Approves Neuralink's First In-Human Clinical Trial

U.S. technology company Neuralink announced that the Food and Drug Administration approved the company's first in-human clinical study for the Link implantable brain-computer interfaces (BCIs), which aim to enable people with extreme paralysis to control external technologies using neural signals, BBC reported on May 25....